title: Cardiac amyloidosis: a case report and therapeutic implications.
abstract: Primary amyloidosis with cardiac involvement presenting as congestive heart failure (CHF) usually carries an unfavorable prognosis, with median survival of about 6 months. We are reporting a case of cardiac amyloidosis with an initial presentation of CHF in which the patient survived for more than 9 years. The prognosis most likely depends on the period of disease remission (i.e., negative serum and urine immunoelectrophoresis), which, in turn, depends on response to chemotherapy.
authors.affiliation: Division of Cardiology, New York Medical College/Westchester Medical Center, Valhalla, New York 10595, USA.
authors.forename: Anu Radha
authors.initials: AR
authors.lastname: Kotha
authors.forename: Melvin B
authors.initials: MB
authors.lastname: Weiss
mesh_terms: D000686:Amyloidosis / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D003937:Diagnosis, Differential; D018450:Disease Progression; D004452:Echocardiography; D006331:Heart Diseases / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D006333:Heart Failure / Q000378:metabolism / Q000628:therapy; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D008297:Male; D008875:Middle Aged